Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STAR-TREC: Can we Save the Rectum by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?

NCT02945566 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT02945566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02945566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STAR-TREC: Can we Save the Rectum by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?
Lead sponsor
University of Birmingham
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
June 14, 2017
Completion date
August 31, 2028
Enrollment
380 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the rectum